Detalhe da pesquisa
1.
Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Clin Gastroenterol Hepatol;
2024 Apr 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38604296
2.
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications.
Clin Gastroenterol Hepatol;
22(4): 789-797.e8, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38048934
3.
Thrombospondin-1 promotes liver fibrosis by enhancing TGF-ß action in hepatic stellate cells.
Biochem Biophys Res Commun;
693: 149369, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38091840
4.
Safety/efficacy of atezolizumab + bevacizumab during anti-platelet/anticoagulation therapy in unresectable hepatocellular carcinoma.
Liver Int;
2024 Jun 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38838097
5.
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study.
Liver Int;
43(10): 2210-2219, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37470077
6.
Artificial intelligence/neural network system that accurately diagnoses hepatocellular carcinoma in nonalcoholic steatohepatitis.
Hepatol Res;
53(12): 1213-1223, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37574654
7.
Impact of fibrosis on liver-related event incidence in nonalcoholic fatty liver disease: A multicenter observational study.
Hepatol Res;
53(12): 1169-1184, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37534742
8.
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease.
Hepatol Res;
53(6): 489-496, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36807720
9.
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter study.
Hepatol Res;
53(4): 312-321, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36524984
10.
Gamma-glutamyl transferase predicts pemafibrate treatment response in non-alcoholic fatty liver disease.
J Gastroenterol Hepatol;
38(10): 1743-1749, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37221601
11.
The PDK1-FoxO1 signaling in adipocytes controls systemic insulin sensitivity through the 5-lipoxygenase-leukotriene B4 axis.
Proc Natl Acad Sci U S A;
117(21): 11674-11684, 2020 05 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32393635
12.
Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
Lab Invest;
102(3): 281-289, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34732847
13.
Serum levels of immunoglobulin M-free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Hepatol Res;
52(12): 998-1008, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35939571
14.
Novel artificial intelligent/neural network system for staging of nonalcoholic steatohepatitis.
Hepatol Res;
51(10): 1044-1057, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34124830
15.
Artificial intelligence/neural network system for the screening of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Hepatol Res;
51(5): 554-569, 2021 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33594747
16.
A novel rapid immunoassay of serum type IV collagen 7S for the diagnosis of fibrosis stage of nonalcoholic fatty liver diseases.
Hepatol Res;
51(3): 263-276, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33350036
17.
Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-ß1/SMAD Signaling and Autophagy in Hepatic Stellate Cells.
Int J Mol Sci;
22(24)2021 Dec 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34948151
18.
Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease.
Liver Int;
40(7): 1686-1692, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32342668
19.
Effect of pemafibrate on fatty acid levels and liver enzymes in non-alcoholic fatty liver disease patients with dyslipidemia: A single-arm, pilot study.
Hepatol Res;
50(12): 1328-1336, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32926754
20.
Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non-alcoholic fatty liver disease.
Hepatol Res;
50(4): 466-477, 2020 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31808236